Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
69.71
-0.19 (-0.27%)
Nov 4, 2024, 4:00 PM EST - Market closed
Belite Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,134 | 1,263 | 750 | - | - |
| Market Cap Growth | 277.55% | 68.44% | - | - | - |
| Enterprise Value | 2,047 | 1,221 | 701 | - | - |
| Last Close Price | 69.71 | 45.75 | 30.14 | - | - |
| PE Ratio | - | -38.46 | -47.61 | - | - |
| PB Ratio | 18.62 | 13.96 | 18.06 | - | - |
| P/FCF Ratio | - | -42.23 | -63.25 | - | - |
| P/OCF Ratio | - | -42.32 | -65.42 | - | - |
| EV/EBITDA Ratio | -34.86 | -38.74 | -54.94 | - | - |
| EV/EBIT Ratio | -34.69 | -38.57 | -54.67 | - | - |
| EV/FCF Ratio | - | -40.85 | -59.14 | - | - |
| Debt / Equity Ratio | - | 0.01 | 0.02 | - | - |
| Debt / FCF Ratio | - | -0.03 | -0.07 | - | - |
| Quick Ratio | - | 24.50 | 20.01 | 10.61 | 26.36 |
| Current Ratio | 29.67 | 24.76 | 20.35 | 10.66 | 26.41 |
| Return on Equity (ROE) | -41.44% | -47.95% | -43.45% | -46.60% | - |
| Return on Assets (ROA) | -25.62% | -28.50% | -25.59% | -27.78% | - |
| Return on Capital (ROIC) | -26.95% | -29.61% | -27.13% | -29.52% | - |
| Earnings Yield | -1.65% | -2.51% | -1.69% | - | - |
| FCF Yield | -2.37% | -1.58% | - | - |
| Buyback Yield / Dilution | -14.96% | -33.12% | -108.74% | -8.87% | - |
| Total Shareholder Return | -14.96% | -33.12% | -108.74% | -8.87% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.